These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 8971389)
1. Chimerism after allogeneic hematopoietic cell transplantation in childhood acute lymphoblastic leukemia. Ramírez M; Díaz MA; García-Sánchez F; Velasco M; Casado F; Villa M; Vicario JL; Madero L Bone Marrow Transplant; 1996 Dec; 18(6):1161-5. PubMed ID: 8971389 [TBL] [Abstract][Full Text] [Related]
2. Chimerism status is a useful predictor of relapse after allogeneic stem cell transplantation for acute leukemia. Barrios M; Jiménez-Velasco A; Román-Gómez J; Madrigal ME; Castillejo JA; Torres A; Heiniger A Haematologica; 2003 Jul; 88(7):801-10. PubMed ID: 12857560 [TBL] [Abstract][Full Text] [Related]
3. Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT. Bader P; Beck J; Frey A; Schlegel PG; Hebarth H; Handgretinger R; Einsele H; Niemeyer C; Benda N; Faul C; Kanz L; Niethammer D; Klingebiel T Bone Marrow Transplant; 1998 Mar; 21(5):487-95. PubMed ID: 9535041 [TBL] [Abstract][Full Text] [Related]
4. Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: possible role for pre-emptive immunotherapy? Bader P; Kreyenberg H; Hoelle W; Dueckers G; Handgretinger R; Lang P; Kremens B; Dilloo D; Sykora KW; Schrappe M; Niemeyer C; Von Stackelberg A; Gruhn B; Henze G; Greil J; Niethammer D; Dietz K; Beck JF; Klingebiel T J Clin Oncol; 2004 May; 22(9):1696-705. PubMed ID: 15117992 [TBL] [Abstract][Full Text] [Related]
5. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia. Mengarelli A; Iori A; Guglielmi C; Romano A; Cerretti R; Torromeo C; Micozzi A; Fenu S; Laurenti L; Donato V; De Felice L; Arcese W Haematologica; 2002 Jan; 87(1):52-8. PubMed ID: 11801465 [TBL] [Abstract][Full Text] [Related]
6. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
7. Effects of chimerism on graft-versus-host disease, disease recurrence, and survival after HLA-identical marrow transplantation in Iran. Alimoghaddam K; Ghaffari H; Foroughi F; Chardouli B; Sanaat Z; Bahar B; Mousavi A; Iravani M; Ghavamzadeh A Arch Iran Med; 2006 Apr; 9(2):99-103. PubMed ID: 16649348 [TBL] [Abstract][Full Text] [Related]
8. Quantitative analysis of chimerism after allogeneic stem cell transplantation by real-time polymerase chain reaction with single nucleotide polymorphisms, standard tandem repeats, and Y-chromosome-specific sequences. Koldehoff M; Steckel NK; Hlinka M; Beelen DW; Elmaagacli AH Am J Hematol; 2006 Oct; 81(10):735-46. PubMed ID: 16838323 [TBL] [Abstract][Full Text] [Related]
9. Allogeneic stem cell transplantation in first complete remission enhances graft-versus-leukemia effect in adults with acute lymphoblastic leukemia: antileukemic activity of chronic graft-versus-host disease. Lee S; Cho BS; Kim SY; Choi SM; Lee DG; Eom KS; Kim YJ; Kim HJ; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Shin WS; Kim CC Biol Blood Marrow Transplant; 2007 Sep; 13(9):1083-94. PubMed ID: 17697971 [TBL] [Abstract][Full Text] [Related]
10. Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Blood and Marrow Transplantation. Antin JH; Childs R; Filipovich AH; Giralt S; Mackinnon S; Spitzer T; Weisdorf D Biol Blood Marrow Transplant; 2001; 7(9):473-85. PubMed ID: 11669214 [TBL] [Abstract][Full Text] [Related]
11. Mixed chimerism in the B cell lineage is a rapid and sensitive indicator of minimal residual disease in bone marrow transplant recipients with pre-B cell acute lymphoblastic leukemia. Zetterquist H; Mattsson J; Uzunel M; Näsman-Björk I; Svenberg P; Tammik L; Bayat G; Winiarski J; Ringdén O Bone Marrow Transplant; 2000 Apr; 25(8):843-51. PubMed ID: 10808205 [TBL] [Abstract][Full Text] [Related]
13. A pilot study of prophylactic donor lymphocyte infusions to prevent relapse in adult acute lymphoblastic leukemias after allogeneic hematopoietic stem cell transplantation. Lutz C; Massenkeil G; Nagy M; Neuburger S; Tamm I; Rosen O; Dörken B; Arnold R Bone Marrow Transplant; 2008 May; 41(9):805-12. PubMed ID: 18195682 [TBL] [Abstract][Full Text] [Related]
14. [Relapse of childhood ALL, AML and MDS after allogeneic stem cell transplantation can be prevented by donor lymphocyte infusion in a critical stage of increasing mixed chimerism]. Beck JF; Klingebiel T; Kreyenberg H; Schaudt A; Wölle W; Niethammer D; Bader P Klin Padiatr; 2002; 214(4):201-5. PubMed ID: 12165902 [TBL] [Abstract][Full Text] [Related]
15. [Application of sequential and quantitative monitoring of chimerism in allogeneic hematopoietic stem cell transplantation]. Tang XW; Wu DP; Zhu ZL; Wang W; Sun AN; Qiu HY; Fu ZZ; Chang WR; Ruan CG Zhonghua Xue Ye Xue Za Zhi; 2004 Feb; 25(2):78-81. PubMed ID: 14990044 [TBL] [Abstract][Full Text] [Related]
16. Prognostic value of hematopoietic chimerism in patients with acute leukemia after allogeneic bone marrow transplantation: a prospective study. Choi SJ; Lee KH; Lee JH; Kim S; Chung HJ; Lee JS; Kim SH; Park CJ; Chi HS; Kim WK Bone Marrow Transplant; 2000 Aug; 26(3):327-32. PubMed ID: 10967574 [TBL] [Abstract][Full Text] [Related]
17. Establishing the method of chimerism monitoring after allogeneic stem cell transplantation using multiplex polymerase chain reaction amplification of short tandem repeat markers and Amelogenin. Sufliarska S; Minarik G; Horakova J; Bodova I; Bojtarova E; Czako B; Mistrik M; Drgona L; Demitrovicova M; Lakota J; Krivosikova M; Kovacs L Neoplasma; 2007; 54(5):424-30. PubMed ID: 17688372 [TBL] [Abstract][Full Text] [Related]
18. Allogeneic stem-cell transplantation in patients with refractory acute leukemia: a long-term follow-up. Oyekunle AA; Kröger N; Zabelina T; Ayuk F; Schieder H; Renges H; Fehse N; Waschke O; Fehse B; Kabisch H; Zander AR Bone Marrow Transplant; 2006 Jan; 37(1):45-50. PubMed ID: 16258531 [TBL] [Abstract][Full Text] [Related]
19. Early complete donor hematopoietic chimerism in peripheral blood indicates the risk of extensive graft-versus-host disease. Balon J; Hałaburda K; Bieniaszewska M; Reichert M; Bieniaszewski L; Piekarska A; Pawłowski R; Hellmann A Bone Marrow Transplant; 2005 Jun; 35(11):1083-8. PubMed ID: 15821766 [TBL] [Abstract][Full Text] [Related]
20. High frequency of donor chimerism after allogeneic transplantation of CD34+-selected peripheral blood cells. Briones J; Urbano-Ispizua A; Lawler M; Rozman C; Gardiner N; Marín P; Salgado C; Féliz P; McCann S; Montserrat E Exp Hematol; 1998 May; 26(5):415-20. PubMed ID: 9590658 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]